COL8A1 and neoplasm: COL8A1-silenced xenograft tumors grew significantly more slowly than those in the control group, with tumor volume and weight in COL8A1-silenced tumors lower than those expressing control shRNA, suggesting that knockdown of COL8A1 suppressed tumor growth capacity in vivo (Figures 6A–C).